Symposium 4: Insuline pumps in artificial páncreas systems

Authors

  • Adrián Proietti Specialized Center (Comprehensive Institute of Diabetes and Applied Technology, IDTA), Autonomous City of Buenos Aires, Argentina

DOI:

https://doi.org/10.47196/diab.v54i3Sup.294

Keywords:

diabetes, insulin

Abstract

Symposium 4: Biology and technology in the treatment of diabetes

Insuline pumps in artificial páncreas systems

By year 2021, insuline discover will reach a centenary. It was the first medication specifically for diabetes treatment and nowadays it is still the safest and most powerful of hypoglycemics. Despite its effectiveness, insuline's greatest challenge has been the occurrence of hypoglycemia, which has resulted in sub-optimal dosing in the prescriptions of nearly every patient.  Most popular devices for insuline administration are syringes, pens and insuline pumps. Closed-loop artificial pancreas systems made for extremely demanding aims seem to be very close to becoming a reality. The development of these systems significantly sped up with the great progress of continuous glucose monitors (CGM) along with computerized algorithms.  

Author Biography

Adrián Proietti, Specialized Center (Comprehensive Institute of Diabetes and Applied Technology, IDTA), Autonomous City of Buenos Aires, Argentina

Doctor, specialist in Endocrinology and Nutrition; Medical Director of the Specialized Center (Integral Institute of Diabetes and Applied Technology, IDTA)

Downloads

Published

2023-01-10

How to Cite

Proietti, A. (2023). Symposium 4: Insuline pumps in artificial páncreas systems. Journal of the Argentine Society of Diabetes, 54(3Sup), 27–27. https://doi.org/10.47196/diab.v54i3Sup.294

Issue

Vol. 54 No. 3Sup (2020): September/December 2020

Section

Symposium Part 2

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Dirección Nacional de Derecho de Autor, Exp. N° 5.333.129. Instituto Nacional de la Propiedad Industrial, Marca «Revista de la Sociedad Argentina de Diabetes - Asociación Civil» N° de concesión 2.605.405 y N° de disposición 1.404/13.

La Revista de la SAD está licenciada bajo Licencia Creative Commons Atribución – No Comercial – Sin Obra Derivada 4.0 Internacional.

Por otra parte, la Revista SAD permite que los autores mantengan los derechos de autor sin restricciones.

 

Similar Articles

1 2 3 4 5 6 7 8 9 10 11 12 13 > >> 

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)